Talpaz M - Search Results

1

Immunological properties of melanoma tumor-infiltrating lymphocytes before and after IL-2-based biotherapies.

Itoh K, Balch CM, Murray JL, Parkinson DR, Markowitz AB, Talpaz M, Lee K, Zukiwski AA, Ross MI, Legha SS, et al. Itoh K, et al. Among authors: talpaz m. In Vivo. 1991 Nov-Dec;5(6):647-53. In Vivo. 1991. PMID: 1810451

2

Alteration in interactions between tumor-infiltrating lymphocytes and tumor cells in human melanomas after chemotherapy or immunotherapy.

Itoh K, Hayakawa K, Salmeron MA, Legha SS, Murray JL, Talpaz M, Balch CM, Parkinson DR, Lee K, Zukiwski AA, et al. Itoh K, et al. Among authors: talpaz m. Cancer Immunol Immunother. 1991;33(4):238-46. doi: 10.1007/BF01744943. Cancer Immunol Immunother. 1991. PMID: 2059968 Free PMC article.

3

Interleukin-2 alone and in combination with other cytokines in melanoma: the investigational approach at the University of Texas M.D. Anderson Cancer Center.

Parkinson DR, Talpaz M, Lee KH, Legha S, Markowitz AB, Itoh K, Balch CM, Murray JL, Zukiwski AA, Benjamin RS, et al. Parkinson DR, et al. Among authors: talpaz m. Cancer Treat Rev. 1989 Jun;16 Suppl A:39-48. doi: 10.1016/0305-7372(89)90021-2. Cancer Treat Rev. 1989. PMID: 2670214 Review.

4

Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study.

Lee KH, Talpaz M, Rothberg JM, Murray JL, Papadopoulos N, Plager C, Benjamin R, Levitt D, Gutterman J. Lee KH, et al. Among authors: talpaz m. J Clin Oncol. 1989 Nov;7(11):1726-32. doi: 10.1200/JCO.1989.7.11.1726. J Clin Oncol. 1989. PMID: 2809685

5

Granulocyte-macrophage colony-stimulating factor as a cause of paraneoplastic leukaemoid reaction in advanced transitional cell carcinoma.

Wetzler M, Estrov Z, Talpaz M, Markowitz A, Gutterman JU, Kurzrock R. Wetzler M, et al. Among authors: talpaz m. J Intern Med. 1993 Oct;234(4):417-20. doi: 10.1111/j.1365-2796.1993.tb00765.x. J Intern Med. 1993. PMID: 7691980

6

Suppression of chronic myelogenous leukemia colony growth by interleukin-4.

Estrov Z, Markowitz AB, Kurzrock R, Wetzler M, Kantarjian HM, Ferrajoli A, Gutterman JU, Talpaz M. Estrov Z, et al. Among authors: talpaz m. Leukemia. 1993 Feb;7(2):214-20. Leukemia. 1993. PMID: 8426475

7

Phase II trial of recombinant human interleukin-2 and interferon-alpha-2a: implications for the treatment of patients with metastatic melanoma.

Eton O, Talpaz M, Lee KH, Rothberg JM, Brell JM, Benjamin RS. Eton O, et al. Among authors: talpaz m. Cancer. 1996 Mar 1;77(5):893-9. Cancer. 1996. PMID: 8608480 Clinical Trial.

8

Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation in a patient with chronic myelogenous leukemia.

Seong D, Bruner JM, Lee KH, Mirza N, Kwon BD, Lee JH, Lee YY, Ro J, Talpaz M, Champlin R, Deisseroth AB. Seong D, et al. Among authors: talpaz m. Clin Infect Dis. 1996 Aug;23(2):402-3. doi: 10.1093/clinids/23.2.402. Clin Infect Dis. 1996. PMID: 8842290 No abstract available.

9

Cutaneous ulcers associated with hydroxyurea therapy in myeloproliferative disorders.

Ravandi-Kashani F, Cortes J, Cohen P, Talpaz M, O'Brien S, Markowitz A, Kantarjian H. Ravandi-Kashani F, et al. Among authors: talpaz m. Leuk Lymphoma. 1999 Sep;35(1-2):109-18. doi: 10.3109/10428199909145710. Leuk Lymphoma. 1999. PMID: 10512168

10

Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors.

Estrov Z, Kurzrock R, Estey E, Wetzler M, Ferrajoli A, Harris D, Blake M, Gutterman JU, Talpaz M. Estrov Z, et al. Among authors: talpaz m. Blood. 1992 Apr 15;79(8):1938-45. Blood. 1992. PMID: 1373331 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

604 results

Search Page

Filters